Enchem (A348370) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 was ₩68.2 billion, down 12.7% year-over-year from ₩78.1 billion in Q1 2024.

• Net income attributable to controlling interests was ₩58.2 billion, a significant turnaround from a net loss of ₩298.3 billion in Q1 2024.

• Basic EPS was ₩2,750, compared to a loss per share of ₩17,387 in the prior year quarter.

Financial highlights

• Gross profit for Q1 2025 was ₩2.93 billion, down from ₩6.21 billion in Q1 2024.

• Operating loss widened to ₩19.16 billion from ₩11.81 billion year-over-year.

• Total assets at March 31, 2025, were ₩1,031.0 billion, down from ₩1,126.9 billion at December 31, 2024.

• Cash and cash equivalents at quarter-end were ₩25.9 billion, down from ₩102.0 billion at the end of the previous quarter.

• Total liabilities decreased to ₩495.7 billion from ₩660.1 billion at year-end 2024.

Outlook and guidance

• Management expects continued ability to generate revenue through product innovation despite global market uncertainties.

• No material risks identified that would impact financial performance or position as of quarter-end.